Clinical features of Acanthamoeba keratitis in contact lens wearers and non-wearers.
Clinical presentations of patients with Acanthamoeba keratitis (AK) attending the Faculty of Medicine Siriraj Hospital during 1996-2006 were reviewed. The studied parameters included history of ocular trauma, use of contact lenses, associated eye diseases, systemic diseases, visual acuity, symptoms, signs, treatment, visual outcomes, and sequelae. Data were analyzed by comparing non-contact lens (nCL) and contact lens (CL) wearers with eachother. Twenty-two patients (24 affected eyes) (68.2% female) had AK, 9 (37.5%) were nCL and 15 (62.5%) were CL. Both groups had similar basic characteristics; however the nCL group was significantly older (48.3 +/- 14.5 vs 30.6 +/- 15.3 years old, p=0.006), and tended to have a longer duration of symptoms with more severe clinical findings, but this was not statistically significant. Eleven had severe ciliary injection (nCL 55.5%, CL 40.0%), 3 had satellite lesions (nCL 22.2%, CL 6.7%), 2 had radial keratoneuritis in the CL group (13.3%), 1 ring infillrate in the nCL group (11.1%) and 1 pseudodendrite in the CL group (6.7%). The mean duration of follow-up was 8.2 +/- 7.9 (ranging 0.3-29) months. Therapeutic measures included anti-Acanthamoeba medications (5/9 for nCL, 8/15 for CL), penetrating keratoplasty due to uncontrolled infections (1/9 for nCL, 2/15 for CL) and corneal perforation (1/9 for nCL), and enucleation due to endophthalmitis (1/9 for CL). At the last follow-up visit, the CL [corrected] group had slightly better visual acuity (55.5% vs 66.7%). In conclusion, AK among patients who do not use contact lenses may have a delayed diagnosis, resulted in more severe ocular manifestations and poorer prognosis. Physicians should be aware of Acanthamoeba infection as a cause of keratitis in any patient, not just contact lens wearers. Long periods of follow-up are recommended to observe for recurrent episodes and proper management of AK patients.
Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Darawan
D
Wanachiwanawin
Wipawee
W
Booranapong
Panida
P
Kosrirukvongs
D015823:Acanthamoeba Keratitis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000503:physiopathology; D060085:Coinfection; D003261:Contact Lenses / Q000009:adverse effects* / Q000469:parasitology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D012959:Socioeconomic Factors; D013785:Thailand / Q000453:epidemiology; D014792:Visual Acuity
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents